Casdin Capital’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Casdin Capital’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,604,275	Closed	-$31.9M	–	42
2023 Q4	$31.9M	Hold	12,604,275	–	–	3.13%	10
2023 Q3	$30.1M	Hold	12,604,275	–	–	3.33%	11
2023 Q2	$29.1M	Hold	12,604,275	–	–	2.54%	16
2023 Q1	$32.1M	Hold	12,604,275	–	–	2.65%	12
2022 Q4	$31.6M	Hold	12,604,275	–	–	2.45%	13
2022 Q3	$36.6M	Buy	12,604,275 +215,193	+2%	+$906K	2.4%	12
2022 Q2	$56M	Hold	12,389,082	–	–	4.73%	7
2022 Q1	$99.4M	Hold	12,389,082	–	–	4.46%	6
2021 Q4	$144M	Hold	12,389,082	–	–	4.06%	9
2021 Q3	$154M	Buy	+12,389,082	New	+$140M	3.82%	9

Casdin Capital's SLGC Position: Q1 2024 in Review

Casdin Capital sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 12,604,275 shares — an estimated $31.9M sold.

Casdin Capital first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $154M in Q3 2021. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Casdin Capital reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Casdin Capital sold 12,604,275 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $31.9M.
Casdin Capital first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
Casdin Capital's SomaLogic, Inc. Class A Common Stock position peaked at $154M in Q3 2021.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Casdin Capital's 13F filing for Q1 2024, filed 15 May 2024.